ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32 | -99.7% | 88,106 | +389.6% | 0.00% | +300.0% |
| Q3 2022 | $11,000 | +22.2% | 17,997 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -60.9% | 18,119 | -30.6% | 0.00% | -50.0% |
| Q1 2022 | $23,000 | -75.5% | 26,101 | -50.4% | 0.00% | -75.0% |
| Q3 2021 | $94,000 | -54.8% | 52,590 | -15.2% | 0.01% | -46.7% |
| Q1 2021 | $208,000 | +700.0% | 61,997 | +346.2% | 0.02% | +400.0% |
| Q4 2020 | $26,000 | -76.4% | 13,895 | -74.5% | 0.00% | -72.7% |
| Q4 2019 | $110,000 | – | 54,386 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |